SonoThera Raises $125 Million for Ultrasound-Delivered Genetic Medicines
The biotechnology company plans to move nonviral treatments for Duchenne muscular dystrophy and polycystic kidney disease toward clinical testing.
Archive
The biotechnology company plans to move nonviral treatments for Duchenne muscular dystrophy and polycystic kidney disease toward clinical testing.
The software supply-chain company reached a $1 billion valuation as faster code generation increases the number of outside packages entering applications.
The new research lab wants software agents to build specialized expertise from experience instead of remaining fixed after training.
The San Francisco mobility company is preparing pilot networks that place small autonomous vehicles on narrow, reserved lanes.
The San Francisco company pairs software agents with growth specialists as brands adjust to search results shaped by traditional engines and AI answers.